Chun Loo Gan

968 total citations
40 papers, 468 citations indexed

About

Chun Loo Gan is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Chun Loo Gan has authored 40 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 14 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Chun Loo Gan's work include Renal cell carcinoma treatment (21 papers), Cancer Genomics and Diagnostics (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Chun Loo Gan is often cited by papers focused on Renal cell carcinoma treatment (21 papers), Cancer Genomics and Diagnostics (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Chun Loo Gan collaborates with scholars based in Canada, United States and Australia. Chun Loo Gan's co-authors include Daniel Y.C. Heng, Shaan Dudani, Frede Donskov, Toni K. Choueiri, Sumanta K. Pal, Benoit Beuselinck, Aaron R. Hansen, J. Connor Wells, Georg A. Bjarnason and Guillermo de Velasco and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and International Journal of Biological Macromolecules.

In The Last Decade

Chun Loo Gan

36 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun Loo Gan Canada 11 355 207 183 153 80 40 468
Annelies Verbiest Belgium 11 242 0.7× 177 0.9× 138 0.8× 116 0.8× 58 0.7× 32 386
Tom Waddell United Kingdom 7 567 1.6× 269 1.3× 427 2.3× 207 1.4× 131 1.6× 18 715
Alejandra Nieto United Kingdom 3 509 1.4× 348 1.7× 184 1.0× 202 1.3× 20 0.3× 4 580
Qi Xia United States 9 216 0.6× 206 1.0× 122 0.7× 134 0.9× 82 1.0× 26 418
Davide Bimbatti Italy 13 398 1.1× 173 0.8× 205 1.1× 158 1.0× 80 1.0× 56 560
Martin Eduardo Richardet Argentina 10 362 1.0× 171 0.8× 353 1.9× 126 0.8× 88 1.1× 21 501
Anna Paola Fraccon Italy 13 425 1.2× 267 1.3× 220 1.2× 184 1.2× 103 1.3× 32 544
B. Escudier France 9 221 0.6× 189 0.9× 94 0.5× 120 0.8× 48 0.6× 41 327
Alketa Hamzaj Italy 8 208 0.6× 117 0.6× 151 0.8× 89 0.6× 57 0.7× 13 295
Mohamad Khasawneh United States 6 223 0.6× 181 0.9× 93 0.5× 106 0.7× 25 0.3× 8 333

Countries citing papers authored by Chun Loo Gan

Since Specialization
Citations

This map shows the geographic impact of Chun Loo Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Loo Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Loo Gan more than expected).

Fields of papers citing papers by Chun Loo Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun Loo Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Loo Gan. The network helps show where Chun Loo Gan may publish in the future.

Co-authorship network of co-authors of Chun Loo Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Chun Loo Gan. A scholar is included among the top collaborators of Chun Loo Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun Loo Gan. Chun Loo Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Mengmeng, Chun Loo Gan, Huimin Jiang, et al.. (2025). Identification of novel pathogenic mutations in ATP6V0A4 associated with distal renal tubular acidosis and analysis of wild-type expression in glomerular disease. Renal Failure. 47(1). 2536729–2536729. 1 indexed citations
2.
Gan, Chun Loo, Dan Chen, Xiao Han, et al.. (2024). Aberrant serum-derived FN1 variants bind to integrin β1 on glomerular endothelial cells contributing to thin basement membrane nephropathy. International Journal of Biological Macromolecules. 281(Pt 1). 136282–136282. 1 indexed citations
3.
Gan, Chun Loo, Xiao Han, Wei Jiang, et al.. (2024). Prediction Model and Decision Analysis for Early Recognition of SDNS/FRNS in Children. Journal of Inflammation Research. Volume 17. 10585–10598.
4.
Tang, Dan, Chun Loo Gan, Mi Bai, et al.. (2023). Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis. Pediatric Nephrology. 39(1). 149–165. 3 indexed citations
5.
Jiang, Wei, Chun Loo Gan, Qing Yang, et al.. (2023). Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease. Cardiovascular Diabetology. 22(1). 293–293. 16 indexed citations
6.
Gan, Chun Loo, Dan Chen, Qing Yang, et al.. (2023). A high-impact FN1 variant correlates with fibronectin-mediated glomerulopathy via decreased binding to collagen type IV. Pathology. 55(4). 498–507. 5 indexed citations
7.
Graham, Jeffrey, J. Connor Wells, Shaan Dudani, et al.. (2022). Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer. 171. 124–132. 20 indexed citations
8.
Jani, Chinmay, Tian Zhang, Nazlı Dizman, et al.. (2022). Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma. Clinical Genitourinary Cancer. 21(1). 55–62. 2 indexed citations
9.
Warkentin, Matthew T., Chun Loo Gan, Safiya Karim, et al.. (2022). Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. European Urology Open Science. 37. 14–26. 53 indexed citations
10.
Gan, Chun Loo, Dan Chen, Hui You, et al.. (2022). Novel pathogenic variants in CUBN uncouple proteinuria from renal function. Journal of Translational Medicine. 20(1). 480–480. 4 indexed citations
11.
Gan, Chun Loo, Igor Stukalin, Daniel E. Meyers, et al.. (2021). Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials. European Journal of Cancer. 151. 115–125. 32 indexed citations
12.
Wells, J. Connor, Shaan Dudani, Chun Loo Gan, et al.. (2021). Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study. Clinical Genitourinary Cancer. 19(4). 354–361. 11 indexed citations
13.
Araújo, Daniel Vilarim, J. Connor Wells, Aaron R. Hansen, et al.. (2021). Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis. Journal of Geriatric Oncology. 12(5). 820–826. 18 indexed citations
14.
Gan, Chun Loo, Shaan Dudani, J. Connor Wells, et al.. (2021). Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).. Journal of Clinical Oncology. 39(6_suppl). 276–276. 9 indexed citations
15.
Gan, Chun Loo, et al.. (2021). Case – Acquired hemophilia A in a patient with metastatic castration-resistant prostate cancer. Canadian Urological Association Journal. 15(9). E519–E521.
16.
Zhou, Xu, Yanping Wang, Shuqing Li, et al.. (2020). Heat-sensitive moxibustion self-administration in patients in the community with primary hypertension. Medicine. 99(38). e22230–e22230. 1 indexed citations
17.
Gan, Chun Loo & Daniel Yick Chin Heng. (2020). New insights into the obesity paradox in renal cell carcinoma. Nature Reviews Nephrology. 16(5). 253–254. 14 indexed citations
18.
Dudani, Shaan, Chun Loo Gan, Ziad Bakouny, et al.. (2020). Application of IMDC criteria across first-line (1L) and second-line (2L) therapies in metastatic renal-cell carcinoma (mRCC): New and updated benchmarks of clinical outcomes.. Journal of Clinical Oncology. 38(15_suppl). 5063–5063. 8 indexed citations
19.
Gan, Chun Loo, Shaan Dudani, & Daniel Y.C. Heng. (2020). Prognostic and Predictive Factors in Metastatic Renal Cell Carcinoma. The Cancer Journal. 26(5). 365–375. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annelies Verbiest Breakdown of academic impact, for papers by Tom Waddell Breakdown of academic impact, for papers by Alejandra Nieto Breakdown of academic impact, for papers by Qi Xia Breakdown of academic impact, for papers by Davide Bimbatti Breakdown of academic impact, for papers by Martin Eduardo Richardet Breakdown of academic impact, for papers by Anna Paola Fraccon Breakdown of academic impact, for papers by B. Escudier Breakdown of academic impact, for papers by Alketa Hamzaj Breakdown of academic impact, for papers by Mohamad Khasawneh
Rankless by CCL
2026